HGH FRAGMENT PEPTIDE (LIPOLYTIC)
AOD-9604
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (hGH) residues 177-191, developed by Metabo...
CATEGORY
6 compounds tracked in this category with source-backed claims and regulatory status.
HGH FRAGMENT PEPTIDE (LIPOLYTIC)
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (hGH) residues 177-191, developed by Metabo...
3 claims · 3 sources · Regulatory watch
GROWTH HORMONE-RELEASING HORMONE (GHRH) ANALOG PEPTIDE
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog developed by ConjuChem with drug affinity complex (DAC) technology fo...
3 claims · 3 sources · Evidence review
GROWTH HORMONE SECRETAGOGUE (GHS) PEPTIDE
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (GHS) that stimulates GH release via ghrelin receptor agonism. It is not ...
3 claims · 3 sources · Evidence review
ORAL GROWTH HORMONE SECRETAGOGUE (GHS) — NON-PEPTIDE
MK-677 (ibutamoren) is a non-peptide, orally active growth hormone secretagogue developed by Merck that mimics ghrelin to stimulate GH and I...
3 claims · 4 sources · Evidence review
GROWTH HORMONE-RELEASING HORMONE (GHRH) ANALOG PEPTIDE
Sermorelin is a synthetic N-terminal fragment (1-29) of growth hormone-releasing hormone (GHRH) that was formerly FDA-approved as Geref for ...
3 claims · 3 sources · Evidence review
GROWTH HORMONE-RELEASING HORMONE (GHRH) ANALOG — FDA-APPROVED (EGRIFTA)
Tesamorelin (brand name Egrifta) is an FDA-approved growth hormone-releasing hormone (GHRH) analog indicated for the reduction of excess vis...
3 claims · 4 sources · Regulatory watch